MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Search

Omnicell Inc

Cerrado

SectorSanidad

29.47 -0.81

Resumen

Variación precio

24h

Actual

Mínimo

29.44

Máximo

29.9

Métricas clave

By Trading Economics

Ingresos

13M

5.6M

Ventas

21M

291M

P/B

Media del Sector

61.04

37.257

Margen de beneficios

1.941

Empleados

3,650

EBITDA

42M

30M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+35.26% upside

Dividendos

By Dow Jones

Próximas Ganancias

30 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

43M

1.4B

Apertura anterior

30.28

Cierre anterior

29.47

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

105 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 oct 2025, 21:45 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 oct 2025, 21:07 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 oct 2025, 17:03 UTC

Principales Movimientos del Mercado

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 oct 2025, 23:53 UTC

Charlas de Mercado

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 oct 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 oct 2025, 21:57 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 oct 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 oct 2025, 21:06 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 20:52 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 oct 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

13 oct 2025, 20:35 UTC

Adquisiciones, fusiones, absorciones

Goldman Expects to Close Deal in 1Q

13 oct 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 oct 2025, 20:29 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Buy VC Firm Industry Ventures

13 oct 2025, 19:05 UTC

Charlas de Mercado

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 oct 2025, 18:59 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 oct 2025, 18:26 UTC

Charlas de Mercado

Precious Metals Close at New Record Highs -- Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 oct 2025, 16:03 UTC

Adquisiciones, fusiones, absorciones

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 oct 2025, 15:35 UTC

Charlas de Mercado

Precious Metals Push Record Highs Further -- Market Talk

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

35.26% repunte

Estimación a 12 Meses

Media 40.2 USD  35.26%

Máximo 55 USD

Mínimo 32 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

4

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

105 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat